One of these mechanisms activates the immune system by inducing cytokine secretion (IL-2 and IFN-gamma) and attracts CD56 natural killer and CD8 cytotoxic lymphocytes into infected cancer tissue (Washburn and Schirrmacher, 2002; Al-Shammari et al., 2011). Here, NCAM1 is linked to cancer.